Yttrium (90Y) tacatuzumab tetraxetan
Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer. The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Yttrium (90Y) tacatuzumab tetraxetan
Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer. The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90, a radioisotope which destroys the tumour cells.
has abstract
L'yttrium (90Y) tacatuzumab te ...... re del farmaco è l'antigene: .
@it
Yttrium (90Y) tacatuzumab tetr ...... ich destroys the tumour cells.
@en
CAS number
476413-07-7
chemical formula
C6470H9971N1712O2007S4290Y
FDA UNII code
GJ2416WK6Y
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
949,605,852
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
chemical formula
C6470H9971N1712O2007S4290Y
@en
ChemSpiderID
none
@en
drug name
Yttrium tacatuzumab tetraxetan
@en
mab type
mab
@en
molecular weight
source
zu/o
@en
target
type
mab
@en
UNII
GJ2416WK6Y
@en
Verifiedfields
changed
@en
verifiedrevid
470,635,003
Watchedfields
changed
@en
wikiPageUsesTemplate
hypernym
comment
L'yttrium (90Y) tacatuzumab te ...... re del farmaco è l'antigene: .
@it
Yttrium (90Y) tacatuzumab tetr ...... ich destroys the tumour cells.
@en
label
Tacatuzumab tetraxetan
@it
Yttrium (90Y) tacatuzumab tetraxetan
@en
isPrimaryTopicOf
name
Yttrium (90Y) tacatuzumab tetraxetan
@en